Business Context and Reporting Period
Company: Stepan Company
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 2007
Business Overview: Stepan produces intermediate chemicals used in consumer and industrial applications. Operations are divided into three segments: Surfactants (73% of H1 2007 sales), Polymers (24%), and Specialty Products (3%).
Key Financial Metrics
| Metric (in thousands) | Q2 2007 | Q2 2006 | H1 2007 | H1 2006 |
|---|---|---|---|---|
| Net Sales | $336,156 | $292,033 | $649,160 | $581,645 |
| Gross Profit | $38,274 | $33,244 | $73,083 | $65,578 |
| Operating Income | $10,519 | $6,959 | $21,051 | $13,138 |
| Net Income | $4,737 | $3,077 | $10,424 | $6,126 |
| Diluted EPS | $0.47 | $0.31 | $1.03 | $0.62 |
| Operating Cash Flow (6mo) | $16,933 (vs $4,125 in H1 2006) | |||
| Total Debt | $138,516 (as of June 30, 2007) | |||
| Cash & Equivalents | $10,487 (as of June 30, 2007) |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 15% in Q2 and 12% in H1 2007 compared to the prior year, driven by a 9% increase in sales volume, favorable currency translation, and higher average selling prices.
- Profitability: Net income rose 54% in Q2 and 70% in H1. Operating income increased 51% in Q2 and 60% in H1.
- Unusual Items:
- Gain on Sale: A $4.3 million pretax gain was recorded in Q2 from the sale of the specialty ester surfactant product line to The HallStar Company.
- Goodwill Impairment: A $3.5 million non-cash charge was recorded in Q2 due to the impairment of goodwill associated with the Stepan UK subsidiary.
- Segment Performance:
- Surfactants: Sales up 11% (Q2) and 8% (H1). Operating income improved despite margin pressure in biodiesel and Latin America.
- Polymers: Sales up 31% (Q2) and 25% (H1). Strong volume growth in polyols offset by rising raw material costs.
Guidance, Outlook, and Risks
- Outlook: Management expects global polyol and North American surfactants to drive profit improvement in the second half of 2007. The company is on track for significant improvement over 2006 results.
- Capital Expenditures: Projected full-year 2007 CapEx is $38.0 million to $42.0 million.
- Subsequent Events: In July 2007, the company froze the Millsdale hourly defined benefit pension plan. This will trigger an estimated $1.4 million in one-time expenses in Q3 2007.
- Environmental & Legal: The company faces ongoing environmental liabilities at 23 sites. The estimated range of possible losses is $10.6 million to $39.7 million, with an accrued liability of $18.9 million. A $3.0 million personal injury settlement related to the Wilmington site was paid in Q1 2007.
- Risks: Key risks include the ability to pass on raw material price increases, foreign currency fluctuations, and the outcome of environmental contingencies.
Investor Verification Checklist
- Non-Recurring Items: Verify the impact of the $4.3 million gain on sale and $3.5 million goodwill impairment on normalized operating income.
- Raw Material Costs: Monitor the ability to pass through rising raw material costs (specifically soybean oil for biodiesel and polyol inputs) to maintain margins.
- Environmental Reserves: Review the adequacy of the $18.9 million accrued liability against the $10.6M–$39.7M estimated loss range for environmental sites.
- Pension Obligations: Track the $1.4 million one-time charge expected in Q3 2007 related to the Millsdale pension plan freeze.
- Debt Levels: Note the increase in consolidated debt to $138.5 million, driven by working capital needs, and monitor compliance with financial covenants.